Net profit of Jagsonpal Pharmaceuticals rose 53.41% to Rs 11.46 crore in the quarter ended September 2024 as against Rs 7.47 crore during the previous quarter ended September 2023. Sales rose 29.15% to Rs 74.69 crore in the quarter ended September 2024 as against Rs 57.83 crore during the previous quarter ended September 2023.
Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
Sales | 74.69 | 57.83 | 29 |
OPM % | 21.81 | 14.47 | - |
PBDT | 17.71 | 10.42 | 70 |
PBT | 15.37 | 9.96 | 54 |
NP | 11.46 | 7.47 | 53 |